Sexual Dysfunction in Palliative Care Patients: An Assessment of Patient's Perspective

February 20, 2024 updated by: M.D. Anderson Cancer Center
To learn about the communications that Supportive Care patients receive about sexual well-being from their healthcare provider. Researchers also want to learn about your attitudes, beliefs, and feelings about sexual well-being.

Study Overview

Status

Active, not recruiting

Conditions

Intervention / Treatment

Detailed Description

Primary Objectives:

  1. To determine the frequency of discussion about sexual dysfunction in palliative care patients.
  2. To evaluate the impact of cancer diagnosis and treatment on patient's sexual life.

Secondary Objectives:

  1. To evaluate patient self-reported severity of sexual dysfunction
  2. To evaluate the proportion of patients suffering distress from body image concerns
  3. To identify patient self-reported barriers that prevent discussion about sexual dysfunction
  4. To evaluate patient self-reported impact of sexual dysfunction on their wellbeing

Study Type

Observational

Enrollment (Estimated)

150

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • United States
    • Texas
      • Houston, Texas, United States, 77030
        • M D Anderson Cancer Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

M D Anderson Cancer Center

Description

Inclusion Criteria:

  • All patients who are evaluated as follow-ups in the Supportive Care clinic, and able to voluntarily consent to participate in the study
  • Patients must be able to understand, read, write, and speak English
  • Diagnosis of cancer
  • Patients who are 18 years of age or older

Exclusion criteria:

  • New patients (consults)
  • Patient who have declined to participate, or who are unable to consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Patient's Perspective
Participants will complete a questionnaire about sexual wellbeing, sexual dysfunction, and communication with your provider on this topic. Participants may choose to complete the questionnaire electronically (via email link), in-person, or over the phone, whichever you prefer. Your demographic information (such as age, gender, ethnicity, marital status, and cancer diagnosis) will be collected from your medical record. Some of this information may also be asked of you during the questionnaire.
Behavioral: Patient's Perspective

Participants will complete a questionnaire about sexual wellbeing, sexual dysfunction, and communication with your provider on this topic.

Participants/Researchers will learn about your attitudes, beliefs, and feelings about sexual well-being

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Quality of Life Questionnaires
Time Frame: through study completion an average of year
through study completion an average of year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

M.D. Anderson Cancer Center

Investigators

  • Principal Investigator: Patricia Bramati, MD, M.D. Anderson Cancer Center

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 15, 2022

Primary Completion (Estimated)

June 1, 2025

Study Completion (Estimated)

June 1, 2025

Study Registration Dates

First Submitted

April 19, 2023

First Submitted That Met QC Criteria

April 19, 2023

First Posted (Actual)

May 1, 2023

Study Record Updates

Last Update Posted (Estimated)

February 21, 2024

Last Update Submitted That Met QC Criteria

February 20, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 2022-0495
  • NCI-2022-10774 (Other Identifier: NCI-CTRP Clinical Trials Registry)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sexual Dysfunction

Clinical Trials on Patient's Perspective

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Canada

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe